Plasma indoleamine 2,3-dioxygenase, a highly sensitive blood-based screening tool for active tuberculosis disease in HIV-infected pregnant women

• C. Adu-Gyamfi,
• L. Mikhathani,
• T. Snyman,
• C. Hoffmann,
• N.A. Martinson,
• R.E. Chaisson,
• J.A. George,
• M.S. Suchard

Affiliations

C. Adu-Gyamfi

National Institute of Communicable Diseases, Centre for Vaccines and Immunology, Johannesburg, South Africa; Corresponding author.

L. Mikhathani

National Institute of Communicable Diseases, Centre for Vaccines and Immunology, Johannesburg, South Africa

T. Snyman

University of the Witwatersrand, Chemical Pathology, Johannesburg, South Africa

C. Hoffmann

John Hopkins Medical Institute, Department of Medicine, Baltimore, MD, United States

N.A. Martinson

Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa

R.E. Chaisson

John Hopkins Medical Institute, Centre for TB Research, Baltimore, MD, United States

J.A. George

University of the Witwatersrand, Chemical Pathology, Johannesburg, South Africa

M.S. Suchard

National Institute of Communicable Diseases, Centre for Vaccines and Immunology, Johannesburg, South Africa